The DOI matches its Crossref record; 214 of the 215 references it cites were found in a registry or an index; none of the 23 sources its claims cite is checked for support yet.
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
Open accessAbstract
IMPORTANCE: Primary care clinicians find managing chronic pain challenging. Evidence of long-term efficacy of opioids for chronic pain is limited. Opioid use is associated with serious risks, including opioid use disorder and overdose. OBJECTIVE: To provide recommendations about opioid prescribing for primary care clinicians treating adult patients with chronic pain outside of active cancer treatment, palliative care, and end-of-life care. PROCESS: The Centers for Disease Control and Prevention (CDC) updated a 2014 systematic review on effectiveness and risks of opioids and conducted a supplemental review on benefits and harms, values and preferences, and costs. CDC used the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework to assess evidence type and determine the recommendation category. EVIDENCE SYNTHESIS: Evidence consisted of observational studies or randomized clinical trials with notable limitations, characterized as low quality using GRADE methodology. Meta-analysis was not attempted due to the limited number of studies, variability in study designs and clinical heterogeneity, and methodological shortcomings of studies. No study evaluated long-term (≥1 year) benefit of opioids for chronic pain. Opioids were associated with increased risks, including opioid use disorder, overdose, and death, with dose-dependent effects. RECOMMENDATIONS: There are 12 recommendations. Of primary importance, nonopioid therapy is preferred for treatment of chronic pain. Opioids should be used only when benefits for pain and function are expected to outweigh risks. Before starting opioids, clinicians should establish treatment goals with patients and consider how opioids will be discontinued if benefits do not outweigh risks. When opioids are used, clinicians should prescribe the lowest effective dosage, carefully reassess benefits and risks when considering increasing dosage to 50 morphine milligram equivalents or more per day, and avoid concurrent opioids and benzodiazepines whenever possible. Clinicians should evaluate benefits and harms of continued opioid therapy with patients every 3 months or more frequently and review prescription drug monitoring program data, when available, for high-risk combinations or dosages. For patients with opioid use disorder, clinicians should offer or arrange evidence-based treatment, such as medication-assisted treatment with buprenorphine or methadone. CONCLUSIONS AND RELEVANCE: The guideline is intended to improve communication about benefits and risks of opioids for chronic pain, improve safety and effectiveness of pain treatment, and reduce risks associated with long-term opioid therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
17 Own result · 3 Not checked yet · 2 Own method · 2 No basis given · 1 Sources not found
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Of primary importance, nonopioid therapy is preferred for treatment of chronic pain. Opioids should be used only when benefits for pain and function are expected to outweigh risks.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > RECOMMENDATIONS
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“When opioids are used, clinicians should prescribe the lowest effective dosage, carefully reassess benefits and risks when considering increasing dosage to 50 morphine milligram equivalents or more per day,”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > RECOMMENDATIONS
None of the sources cited for this claim could be matched to a paper in Crossref, so there is nothing to check it against.
In the paper
“Several nonpharmacologic and nonopioid pharmacologic treatments were found to be effective for chronic pain in studies ranging in duration from 2 weeks to 6 months48–66 (Table 3).”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Guideline Development Process > Contextual Evidence Review
What the sources say
- Not matchedcites [48]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [49]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [50]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [51]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [52]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [53]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [54]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [55]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [56]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [57]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matched
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“No study evaluated long-term (≥1 year) benefit of opioids for chronic pain.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > EVIDENCE SYNTHESIS
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The recommendations in the guideline are voluntary, rather than prescriptive standards. They are based on emerging evidence, including observational studies or randomized clinical trials with notable limitations.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > CONCLUSIONS AND RELEVANCE
None of the sources cited for this claim have been checked yet.
In the paper
“Studies examining patients who underwent low-risk surgery or experienced low back pain from injury revealed that opioid therapy prescribed for acute pain was associated with greater likelihood of long-term use.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Guideline Development Process > Clinical Evidence Review
What the sources say
- Not checked yetcites [46]
- Not checked yetcites [47]
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“No study evaluated the effectiveness of risk mitigation strategies.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Guideline Development Process > Clinical Evidence Review
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Evidence consisted of observational studies or randomized clinical trials with notable limitations, characterized as low quality using GRADE methodology.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > EVIDENCE SYNTHESIS
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Opioids were associated with increased risks, including opioid use disorder, overdose, and death, with dose-dependent affects.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > EVIDENCE SYNTHESIS
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Before starting opioids, clinicians should establish treatment goals with patients and consider how opioids will be discontinued if benefits do not outweigh risks.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > RECOMMENDATIONS
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“A study of almost 100,000 patients found that the average rate of tapering was 34.0% of the original dose per month and more than a quarter of patients were tapering at a rate faster than 40% of their original dose per month,43,49 even higher than the maximum rate recommended by the CDC. 1”
From Tapering and withdrawing opioids: guidance informed by fundamental principles to minimise withdrawal symptoms (2025) · cites this paper as [1]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, opioids are significantly less effective against chronic pain, such as neuropathic pain, fibromyalgia, and low-back pain, and tolerance develops to the analgesic effects of opioids, thus necessitating the need for increasingly higher doses to sustain analgesia (McQuay, 1988;Dowell et al., 2016).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Dowell et al., 2016
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The influential Centres for Disease Control (CDC) Guideline for Prescribing Opioids recommends a linear reduction of opioid doses: ‘A decrease of 10% of the original dose per week’ or ‘slower tapers (e.g. 10% per month)’ for longer term users (Figure 1(a)). 1”
From Tapering and withdrawing opioids: guidance informed by fundamental principles to minimise withdrawal symptoms (2025) · cites this paper as [1]
In the citing paper
“Opioids are also associated with substantial systemic harm such as worsening psychopathology, addiction, tolerance, and premature death. 24”
From Rome IV Functional Gastrointestinal Disorders and Health Impairment in Subjects With Hypermobility Spectrum Disorders or Hypermobile Ehlers-Danlos Syndrome (2021) · cites this paper as [24]
In the citing paper
“The Centers for Disease Control and Prevention and US Food and Drug Administration issued warnings in 2016 to make prescribers and patients aware of these risks.19,34”
From Patterns in Outpatient Benzodiazepine Prescribing in the United States (2019) · cites this paper as [34]
In the citing paper
“evidence of their longterm efficacy and safety is limited.6”
From Mind-Body Therapies for Opioid-Treated Pain: A Systematic Review and Meta-analysis (2020) · cites this paper as [6]
In the citing paper
“Although opioids are considered to be useful in managing a wide continuum of pain, including acute, procedural, and chronic pain”
From Mind-Body Therapies for Opioid-Treated Pain: A Systematic Review and Meta-analysis (2020) · cites this paper as [6]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
GRADE guidelines: 3. Rating the quality of evidence
Balshem, H., Helfand, M., Schünemann, H. J., Oxman, A. D., Kunz, R., Brozek, J., Vist, G. E., Falck-Ytter, Y., Meerpohl, J., & Norris, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.015 · Cited by 8,285
Kroenke, K., Spitzer, R. L., Williams, J. B. W., & Löwe, B. (2010) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2010.03.006 · Cited by 4,057
GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology
Guyatt, G. H., Oxman, A. D., Schünemann, H. J., Tugwell, P., & Knottnerus, A. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.09.011 · Cited by 3,094
Hochberg, M. C., Altman, R. D., April, K. T., Benkhalti, M., Guyatt, G., McGowan, J., Towheed, T., Welch, V., Wells, G., & Tugwell, P. (2012) · Arthritis Care & Research · doi:10.1002/acr.21596 · Cited by 3,068
Zhang, W., Moskowitz, R. W., Nuki, G., Abramson, S., Altman, R. D., Arden, N., Bierma-Zeinstra, S., Brandt, K. D., Croft, P., Doherty, M., et al. (2008) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2007.12.013 · Cited by 2,796
Chou, R., Qaseem, A., Snow, V., Casey, D., Cross, J. T., Shekelle, P., Owens, D. K., & for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians and the American College of Physicians/American Pain Society Low Back Pain Guidelines Panel* (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-7-200710020-00006 · Cited by 2,718
Self-citationCDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016
Dowell, D., Haegerich, T. M., & Chou, R. (2016) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6501e1 · Cited by 2,697
Self-citationPsychosomatic medicine in Germany: more timely than ever
Zipfel, S., Herzog, W., Kruse, J., & Henningsen, P. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447701 · Cited by 2,323
Cited by
Sorted by citations
Items 701–800 of 1,036
Lentz, T. A., Beneciuk, J. M., & George, S. Z. (2018) · BMC Health Services Research · doi:10.1186/s12913-018-3470-6 · Cited by 52
Pain polymorphisms and opioids: An evidence based review
Vieira, C., Fragoso, R. M., Pereira, D., & Medeiros, R. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9792 · Cited by 49
Vowles, K. E., Witkiewitz, K., Cusack, K. J., Gilliam, W. P., Cardon, K. E., Bowen, S., Edwards, K. A., McEntee, M. L., & Bailey, R. W. (2020) · The Journal of Pain · doi:10.1016/j.jpain.2019.11.007 · Cited by 49
Canadian Guidelines on Opioid Use Disorder Among Older Adults
Rieb, L. M., Samaan, Z., Furlan, A. D., Rabheru, K., Feldman, S., Hung, L., Budd, G., & Coleman, D. (2020) · Canadian Geriatrics Journal · doi:10.5770/cgj.23.420 · Cited by 55
Assessment of Physician Prescribing of Muscle Relaxants in the United States, 2005-2016
Soprano, S. E., Hennessy, S., Bilker, W. B., & Leonard, C. E. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.7664 · Cited by 52
Transforming low back pain care delivery in the United States
George, S. Z., Goertz, C., Hastings, S. N., & Fritz, J. M. (2020) · Pain · doi:10.1097/j.pain.0000000000001989 · Cited by 49
Sihota, A., Smith, B. K., Ahmed, S., Bell, A., Blain, A., Clarke, H. A., Cooper, Z. D., Cyr, C., Daeninck, P. J., Deshpande, A., et al. (2020) · International Journal of Clinical Practice · doi:10.1111/ijcp.13871 · Cited by 50
Gupta, M., Knežević, N. N., Abd-Elsayed, A. A., Ray, M., Patel, K. V., & Chowdhury, B. (2021) · Biomedicines · doi:10.3390/biomedicines9050573 · Cited by 53
Child, S. T., Nicklett, E. J., Stauber, D. B., & Ward, D. M. (2021) · American Public Health Association eBooks · doi:10.2105/9780875533162ch09 · Cited by 49
Considerations for neonatal and pediatric pain management
Shah, P. A., & Siu, A. (2019) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxz166 · Cited by 49
Opioids for chronic pain management in patients with dialysis-dependent kidney failure
Tobin, D. G., Lockwood, M. B., Kimmel, P. L., Dember, L. M., Eneanya, N. D., Jhamb, M., Nolin, T. D., Becker, W. C., & Fischer, M. J. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00484-6 · Cited by 55
Bennett, A. S., Guarino, H., Britton, P. C., O'Brien-Mazza, D., Cook, S., Taveras, F., Cortez, J., & Elliott, L. C. (2022) · Annals of Medicine · doi:10.1080/07853890.2022.2092896 · Cited by 52
Acute Pain Management Pearls: A Focused Review for the Hospital Clinician
Hyland, S. J., Wetshtein, A. M., Grable, S., & Jackson, M. P. (2022) · Healthcare · doi:10.3390/healthcare11010034 · Cited by 48
Safety concerns with long-term opioid use
Harned, M. E., & Sloan, P. A. (2016) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2016.1177509 · Cited by 48
Cost Utility Analysis of Cervical Therapeutic Medial Branch Blocks in Managing Chronic Neck Pain
Manchikanti, L., Pampati, V., Kaye, A. D., & Hirsch, J. A. (2017) · International Journal of Medical Sciences · doi:10.7150/ijms.20755 · Cited by 48
Managing Concerning Behaviors in Patients Prescribed Opioids for Chronic Pain: A Delphi Study
Merlin, J. S., Young, S. R., Starrels, J. L., Azari, S., Edelman, E. J., Pomeranz, J. L., Roy, P. J., Saini, S., Becker, W. C., & Liebschutz, J. M. (2017) · Journal of General Internal Medicine · doi:10.1007/s11606-017-4211-y · Cited by 48
The Assessment and Management of Pain in Cirrhosis
Klinge, M. J., Coppler, T., Liebschutz, J. M., Dugum, M. F., Wasan, A. D., DiMartini, A. F., & Rogal, S. S. (2018) · Current Hepatology Reports · doi:10.1007/s11901-018-0389-7 · Cited by 51
McPherson, S., Smith, C. L., Dobscha, S. K., Morasco, B. J., Demidenko, M. I., Meath, T. H. A., & Lovejoy, T. I. (2018) · Pain · doi:10.1097/j.pain.0000000000001315 · Cited by 48
The Deepening Opioid Crisis in North America: Historical Context and Current Solutions
Donroe, J. H., Socias, M. E., & Marshall, B. D. L. (2018) · Current Addiction Reports · doi:10.1007/s40429-018-0228-5 · Cited by 54
Persistent Opioid Use and High-Risk Prescribing in Body Contouring Patients
Bennett, K. G., Kelley, B., Vick, A. D., Lee, J. S.-J., Gunaseelan, V., Brummett, C. M., & Waljee, J. F. (2018) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000005084 · Cited by 48
Comparing different chronic preoperative opioid use definitions on outcomes after spine surgery
Oleisky, E. R., Pennings, J. S., Hills, J. M., Sivaganesan, A., Khan, I., Call, R., Devin, C. J., & Archer, K. R. (2019) · The Spine Journal · doi:10.1016/j.spinee.2018.12.014 · Cited by 48
Nursing Education in the Midst of the Opioid Crisis
Compton, P. A., & Blacher, S. (2019) · Pain Management Nursing · doi:10.1016/j.pmn.2019.06.006 · Cited by 51
Bonakdar, R. A., Palanker, D., & Sweeney, M. (2019) · Global Advances in Health and Medicine · doi:10.1177/2164956119855629 · Cited by 49
Racial Inequities in U.S. Naloxone Prescriptions
Madden, E. F., & Qeadan, F. (2019) · Substance Abuse · doi:10.1080/08897077.2019.1686721 · Cited by 50
Garland, E. L., Hudak, J., Hanley, A. W., & Nakamura, Y. (2020) · American Psychologist · doi:10.1037/amp0000638 · Cited by 54
Bellnier, T., Brown, G. W., & Ortega, T. R. (2018) · Mental Health Clinician · doi:10.9740/mhc.2018.05.110 · Cited by 48
Is it time US dentistry ended its opioid dependence?
Thornhill, M. H., Suda, K. J., Durkin, M. J., & Lockhart, P. B. (2019) · The Journal of the American Dental Association · doi:10.1016/j.adaj.2019.07.003 · Cited by 50
Deprescribing Opioids in Chronic Non-cancer Pain: Systematic Review of Randomised Trials
Mathieson, S., Maher, C. G., Ferreira, G. E., Hamilton, M., Jansen, J., McLachlan, A. J., Underwood, M. R., & Lin, C. C. (2020) · Drugs · doi:10.1007/s40265-020-01368-y · Cited by 49
Evaluation of Buprenorphine Rotation in Patients Receiving Long-term Opioids for Chronic Pain
Powell, V. D., Rosenberg, J. M., Yaganti, A., Garpestad, C., Lagisetty, P., Shannon, C., & Silveira, M. J. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.24152 · Cited by 50
Peripheral Neuroinflammation and Pain: How Acute Pain Becomes Chronic
Schumacher, M. A. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230808111908 · Cited by 53
“Opioids, although effective for acute pain at rest, and advancing cancer pain, may poorly control chronic pain and/or hypersensitivity associated with movement [85, 86].”
BackgroundRahman, Q. A., Janmohamed, T., Pirbaglou, M., Ritvo, P., Heffernan, J. M., Clarke, H. A., & Katz, J. D. (2017) · JMIR mhealth and uhealth · doi:10.2196/mhealth.7871 · Cited by 46
Update of HIV-Associated Sensory Neuropathies
Aziz-Donnelly, A., & Harrison, T. B. (2017) · Current Treatment Options in Neurology · doi:10.1007/s11940-017-0472-3 · Cited by 47
Forecasting the future burden of opioids for osteoarthritis
Ackerman, I. N., Zomer, E., Gilmartin‐Thomas, J., & Liew, D. (2017) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2017.11.001 · Cited by 47
Guarino, H., Fong, C., Marsch, L. A., Acosta, M. C., Syckes, C., Moore, S. K., Cruciani, R. A., Portenoy, R. K., Turk, D. C., & Rosenblum, A. (2017) · Pain Medicine · doi:10.1093/pm/pnx334 · Cited by 51
Silva, L. O. J. E., Scherber, K., Cabrera, D., Motov, S. M., Erwin, P. J., West, C. P., Murad, M. H., & Bellolio, F. (2018) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2017.12.014 · Cited by 47
Endogenous Pain Modulation Profiles Among Individuals With Chronic Pain: Relation to Opioid Use
Martel, M. O., Petersen, K. K., Cornelius, M. C., Arendt‐Nielsen, L., & Edwards, R. R. (2018) · Journal of Pain · doi:10.1016/j.jpain.2018.10.004 · Cited by 50
Identifying opioid prescribing patterns for high-volume prescribers via cluster analysis
Nataraj, N., Zhang, K., Guy, G. P., & Losby, J. L. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.01.012 · Cited by 49
Optimizing opioid prescribing and pain treatment for surgery: Review and conceptual framework
Bicket, M. C., Brat, G. A., Hutfless, S. M., Wu, C. L., Nesbit, S. A., & Alexander, G. C. (2019) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxz146 · Cited by 48
Chronic Pain Following Cosmetic Breast Surgery: A Comprehensive Review
Urits, I., Lavin, C. V., Patel, M., Maganty, N. V., Jacobson, X., Ngo, A. L., Urman, R. D., Kaye, A. D., & Viswanath, O. (2020) · Pain and Therapy · doi:10.1007/s40122-020-00150-y · Cited by 47
Adeyemo, E., Aoun, S. G., Barrie, U., Nguyen, M. L., Badejo, O., Pernik, M. N., Christian, Z. K., Dosselman, L. J., Ahmadieh, T. Y. E., Hall, K., et al. (2020) · Neurosurgery · doi:10.1093/neuros/nyaa399 · Cited by 47
Hudak, J., Hanley, A. W., Marchand, W. R., Nakamura, Y., Yabko, B. A., & Garland, E. L. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-00831-4 · Cited by 49
MacCallum, C. A., Eadie, L., Barr, A. M., Boivin, M. R., & Lu, S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.633168 · Cited by 72
Bringing chronic-pain care to rural veterans: A telehealth pilot program description.
Glynn, L. H., Chen, J. A., Dawson, T. C., Gelman, H., & Zeliadt, S. B. (2021) · Psychological Services · doi:10.1037/ser0000408 · Cited by 40
Opioid Abuse And Poisoning: Trends In Inpatient And Emergency Department Discharges
Tedesco, D., Asch, S. M., Curtin, C. M., Hah, J. M., McDonald, K. M., Fantini, M. P., & Hernandez‐Boussard, T. (2017) · Health Affairs · doi:10.1377/hlthaff.2017.0260 · Cited by 48
Feldman, D. E., Carlesso, L. C., & Nahin, R. L. (2019) · Journal of Pain · doi:10.1016/j.jpain.2019.11.014 · Cited by 46
Garland, E. L., Hanley, A. W., Hudak, J., Nakamura, Y., & Froeliger, B. (2022) · Science Advances · doi:10.1126/sciadv.abo4455 · Cited by 51
Potent Inhibition of hERG Channels by the Over-the-Counter Antidiarrheal Agent Loperamide
Klein, M. G., Haigney, M. C., Mehler, P. S., Fatima, N., Flagg, T. P., & Krantz, M. J. (2016) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2016.07.008 · Cited by 46
Something for pain: Responsible opioid use in emergency medicine
Strayer, R. J., Motov, S. M., & Nelson, L. S. (2016) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2016.10.043 · Cited by 49
Cebranopadol: novel dual opioid/NOP receptor agonist analgesic
Raffa, R. B., Burdge, G., Gambrah, J., Kinecki, H. E., Lin, F., Lu, B., Nguyen, J. T., Phan, V. T., Ruan, A., Sesay, M. A., et al. (2016) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12461 · Cited by 46
Primary Care Clinic Re-Design for Prescription Opioid Management
Parchman, M. L., Korff, M. V., Baldwin, L., Stephens, M., Ike, B. R., Cromp, D., Hsu, C. W., & Wagner, E. H. (2017) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2017.01.160183 · Cited by 47
Polypharmacy and Adherence to Adjuvant Endocrine Therapy for Breast Cancer
Calip, G. S., Xing, S., Jun, D.-H., Lee, W., Hoskins, K. F., & Ko, N. Y. (2017) · Journal of Oncology Practice · doi:10.1200/jop.2016.018317 · Cited by 48
Bishop, F. L., Coghlan, B., Geraghty, A. W. A., Everitt, H., Little, P. S., Holmes, M. M., Seretis, D., & Lewith, G. T. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-015516 · Cited by 49
Pharmaceutical opioid use and harm in Australia: The need for proactive and preventative responses
Larance, B., Degenhardt, L. J., Peacock, A., Gisev, N., Mattick, R. P., Colledge‐Frisby, S., & Campbell, G. (2017) · Drug and Alcohol Review · doi:10.1111/dar.12617 · Cited by 47
Rethinking Opioid Dose Tapering, Prescription Opioid Dependence, and Indications for Buprenorphine
Chou, R., Ballantyne, J. C., & Lembke, A. (2019) · Annals of Internal Medicine · doi:10.7326/m19-1488 · Cited by 46
Self-citationStrayer, R. J., Hawk, K. F., Hayes, B. D., Herring, A. A., Ketcham, E. M., LaPietra, A. M., Lynch, J. J., Motov, S. M., Repanshek, Z. D., Weiner, S. G., et al. (2020) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2019.12.034 · Cited by 47
Long-Term Opioid Prescriptions After Spine Surgery: A Meta-Analysis of Prevalence and Risk Factors
Lo, Y. T., Lim-Watson, M. Z., Seo, Y., Fluetsch, N., Alasmari, M. M., Alsheikh, M. Y., Lamba, N., Smith, T. R., Aglio, L. S., & Mekary, R. A. (2020) · World Neurosurgery · doi:10.1016/j.wneu.2020.06.081 · Cited by 49
McGinty, E. E., Bicket, M. C., Seewald, N. J., Stuart, E. A., Alexander, G. C., Barry, C. L., McCourt, A. D., & Rutkow, L. (2022) · Annals of Internal Medicine · doi:10.7326/m21-4363 · Cited by 46
“The latter 2 measures are indicators of high-risk prescriptions associated with increased risk for addiction and overdose (9).”
BackgroundWelsch, P., Petzke, F. W., Klose, P., & Häuser, W. (2019) · European Journal of Pain · doi:10.1002/ejp.1522 · Cited by 46
Bouvier, B. A., Waye, K. M., Elston, B., Hadland, S. E., Green, T. C., & Marshall, B. D. L. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.10.023 · Cited by 45
Al-Kaisy, A. A., Buyten, J. V., Carganillo, R., Caraway, D. L., Gliner, B. E., Subbaroyan, J., Panwar, C. E., Rotte, A., Amirdelfan, K., & Kapural, L. (2019) · Scientific Reports · doi:10.1038/s41598-019-47792-3 · Cited by 47
Review of nonopioid multimodal analgesia for surgical and trauma patients
George, S., & Johns, M. L. (2020) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxaa301 · Cited by 56
Persistent moderate to severe pain and long‐term cognitive decline
Wei, R., Zhang, C., Zheng, F., Xiao, S., Yang, Z., & Xie, W. (2021) · European Journal of Pain · doi:10.1002/ejp.1826 · Cited by 45
“However, pharmacological treatment still has substantial risks, such as gastrointestinal, liver, cardiorenal toxicity, overdose, addiction potential and so on (Dowell et al., 2016; Kosugi et al., 2017).”
BackgroundTay, H. P., Wang, X., Narayan, S. W., Penm, J. H.-D., & Patanwala, A. E. (2021) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxab367 · Cited by 45
Benzodiazepine-Involved Overdose Deaths in the USA: 2000–2019
Kleinman, R. A., & Weiss, R. D. (2022) · Journal of General Internal Medicine · doi:10.1007/s11606-021-07035-6 · Cited by 45
Boehnke, K. F., Sinclair, R., Gordon, F., Hosanagar, A., Roehler, D. R., Smith, T., & Hoots, B. (2024) · Annals of Internal Medicine · doi:10.7326/m23-2811 · Cited by 48
“Further, inadequate relief from conventional pain medications (20, 21), including opioids (22, 23), has led some patients to seek alternative treatment options (24).”
BackgroundSakamoto, J. T., Ward, H. B., Vissoci, J. R. N., & Eucker, S. A. (2018) · Academic Emergency Medicine · doi:10.1111/acem.13411 · Cited by 45
Smolina, K., Crabtree, A., Chong, M., Zhao, B., Park, M., Mill, C., & Schütz, C. G. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.09.019 · Cited by 49
The Strengths and Weaknesses of Current US Policy to Address Pain
Gross, J. B., & Gordon, D. B. (2018) · American Journal of Public Health · doi:10.2105/ajph.2018.304746 · Cited by 44
Patterns and predictors of chronic opioid use in older adults: A retrospective cohort study
Oh, G., Abner, E. L., Fardo, D. W., Freeman, P. R., & Moga, D. C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210341 · Cited by 47
Prescription opioids, alcohol and fatal motor vehicle crashes: a population-based case-control study
Li, G., & Chihuri, S. T. (2019) · Injury Epidemiology · doi:10.1186/s40621-019-0187-x · Cited by 45
Flipping the Pain Care Model: A Sociopsychobiological Approach to High-Value Chronic Pain Care
Mardian, A. S., Hanson, E. R., Villarroel, L., Karnik, A. D., Sollenberger, J. G., Okvat, H. A., Dhanjal-Reddy, A., & Rehman, S. U. (2019) · Pain Medicine · doi:10.1093/pm/pnz336 · Cited by 49
Leveraging Digital Data to Inform and Improve Quality Cancer Care
Hernandez‐Boussard, T., Blayney, D. W., & Brooks, J. D. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-0873 · Cited by 45
The Physiology and Maintenance of Respiration: A Narrative Review
Webster, L. R., & Karan, S. (2020) · Pain and Therapy · doi:10.1007/s40122-020-00203-2 · Cited by 57
Desai, R. J., Jin, Y., Franklin, P. D., Lee, Y., Bateman, B. T., Lii, J., Solomon, D. H., Katz, J. N., & Kim, S. C. (2019) · Arthritis & Rheumatology · doi:10.1002/art.40834 · Cited by 43
Chiuve, S. E., Kilpatrick, R. D., Hornstein, M. D., Petruski‐Ivleva, N., Wegrzyn, L. R., Dabrowski, E. C., Velentgas, P., Snabes, M. C., & Bateman, B. T. (2021) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5209 · Cited by 45
Omega-3 Fatty Acids for the Management of Osteoarthritis: A Narrative Review
Cordingley, D. M., & Cornish, S. M. (2022) · Nutrients · doi:10.3390/nu14163362 · Cited by 49
“Opioids are another pharmacological option; however, their use is not recommended over nonopioid options due to the potential risks associated with their consumption [20].”
BackgroundPublic Health Detailing—A Successful Strategy to Promote Judicious Opioid Analgesic Prescribing
Kattan, J. A., Tuazon, E. D., Paone, D., Dowell, D., Võ, L. T., Starrels, J. L., Jones, C. M., & Kunins, H. V. (2016) · American Journal of Public Health · doi:10.2105/ajph.2016.303274 · Cited by 46
Self-citationFaul, M., Bohm, M. K., & Alexander, C. (2017) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6612a2 · Cited by 44
Women and the opioid crisis: historical context and public health solutions
Terplan, M. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.06.007 · Cited by 48
Surgical interns: Preparedness for opioid prescribing before and after a training intervention
Nooromid, M. J., Mansukhani, N. A., Deschner, B. W., Moradian, S., Issa, N., Ho, K. J., & Stulberg, J. J. (2017) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2017.11.017 · Cited by 44
Physicians Report Adopting Safer Opioid Prescribing Behaviors after Academic Detailing Intervention
Larson, M. J., Browne, C. A., Nikitin, R. V., Wooten, N. R., Ball, S. J., Adams, R. S., & Barth, K. S. (2018) · Substance Abuse · doi:10.1080/08897077.2018.1449175 · Cited by 46
Beneciuk, J. M., Lentz, T. A., He, Y., Wu, S. S., & George, S. Z. (2018) · Physical Therapy · doi:10.1093/ptj/pzy021 · Cited by 45
Vowles, K. E., Witkiewitz, K. A., Pielech, M., Edwards, K. A., McEntee, M. L., Bailey, R. W., Bolling, L. A., & Sullivan, M. D. (2018) · Journal of Pain · doi:10.1016/j.jpain.2018.04.013 · Cited by 44
Assessing and Treating Chronic Pain in Patients with End-Stage Renal Disease
Coluzzi, F. (2018) · Drugs · doi:10.1007/s40265-018-0980-9 · Cited by 44
Noureldin, M., Higgins, P., Govani, S. M., Cohen‐Mekelburg, S., Kenney, B. C., Stidham, R. W., Waljee, J. F., & Waljee, A. K. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15023 · Cited by 44
Lau, M. K., Bounthavong, M., Kay, C. L., Harvey, M., & Christopher, M. L. D. (2019) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2018.12.006 · Cited by 46
Tang, N. K. Y., Stella, M. T., Banks, P. D. W., Sandhu, H. K., & Berna, C. (2019) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2019.03.005 · Cited by 44
Chronic Postoperative Opioid Use: A Systematic Review
Hinther, A. V., Abdel-Rahman, O. M., Cheung, W. Y., Quan, M. L., & Dort, J. C. (2019) · World Journal of Surgery · doi:10.1007/s00268-019-05016-9 · Cited by 44
Feehan, A. K., & Zadina, J. E. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1480-x · Cited by 45
Glaser, G. E., Kalogera, E., Kumar, A., Yi, J., DeStephano, C. C., Ubl, D. S., Glasgow, A. E., Habermann, E. B., & Dowdy, S. C. (2020) · Gynecologic Oncology · doi:10.1016/j.ygyno.2020.02.025 · Cited by 44
Hermann, G. M., Iovoli, A. J., Platek, A. J., Wang, C., Miller, A., Attwood, K. M., Bourgeois, D. J., & Singh, A. K. (2019) · Cancer · doi:10.1002/cncr.32676 · Cited by 45
Ho, J. F. V., Yaakup, H., Low, G. S. H., Wong, S. L., Tho, L. M., & Beng, T. S. (2020) · Palliative Medicine · doi:10.1177/0269216320904905 · Cited by 44
McAfee, J., Boehnke, K. F., Moser, S. E., Brummett, C. M., Waljee, J. F., & Bonar, E. E. (2020) · Regional Anesthesia & Pain Medicine · doi:10.1136/rapm-2020-101812 · Cited by 47
Kirla, K. T., Erhart, C., Groh, K. J., Stadnicka-Michalak, J., Eggen, R. I. L., Schirmer, K., & Kræmer, T. (2021) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2021.115483 · Cited by 47
Wilson, J. D., Abebe, K. Z., Kraemer, K. L., Liebschutz, J. M., Merlin, J. S., Miller, E. A., Kelley, D., & Donohue, J. M. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.4552 · Cited by 44
Epidemiology of trigeminal neuralgia: an electronic population health data study in Korea
Lee, C.-H., Jang, H.-Y., Won, H., Kim, J.-S., & Kim, Y.-D. (2021) · The Korean journal of pain · doi:10.3344/kjp.2021.34.3.332 · Cited by 47
Cost-effectiveness of Multidisciplinary Interventions for Chronic Low Back Pain
Chowdhury, A. R., Graham, P. L., SCHOFIELD, D. J., Cunich, M., & Nicholas, M. (2021) · Clinical Journal of Pain · doi:10.1097/ajp.0000000000001009 · Cited by 46
Federal and State Policy Efforts to Address Maternal Opioid Misuse: Gaps and Challenges
Saunders, J. B., Jarlenski, M., Levy, R. J., & Kozhimannil, K. B. (2017) · Women s Health Issues · doi:10.1016/j.whi.2017.10.011 · Cited by 45
George, S. Z., Lentz, T. A., & Goertz, C. (2021) · Translational research · doi:10.1016/j.trsl.2021.04.006 · Cited by 44
Mullin, S., Zola, J., Lee, R., Hu, J.-W., Mackenzie, B., Brickman, A., Anaya, G., Sinha, S., Li, A., & Elkin, P. (2021) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2021.103889 · Cited by 44
“Since CDC guidelines recommend prescriptions less than 90 MME/day, and furthermore, caution increasing dosages to greater than 50 MME per day, this cluster provides very little insight that would be useful in clinical practice [53].”
Background
Metadata
- Authors
- Dowell, D., Haegerich, T. M., & Chou, R.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Corresponding author
- Dowell, Deborah
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2016-04-19
- Volume
- 315
- Issue
- 15
- Pages
- 1624
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- PMC
- PMC6390846
- OpenAlex
- W2296986887
- Cited by
- 5,161
- References
- 215
- Citations by year
- 2026: 137 · 2025: 233 · 2024: 272 · 2023: 347 · 2022: 407 · 2021: 733 · 2020: 825 · 2019: 762 · 2018: 701 · 2017: 525 · 2016: 214
- FWCI
- 723.61
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (CC999999)
- Agency for Healthcare Research and Quality
- U.S. Public Health Service (200-2013-M-53890, 15IPA-1505478, 290201200014I)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Pain Management
- Keywords
- opioid prescribing, chronic pain, opioid use disorder, opioid overdose, benzodiazepines, prescription drug monitoring programs, buprenorphine, methadone, medication-assisted treatment, low-dose opioids, primary care
- MeSH terms
- Contraindications, Adult, Analgesics, Opioid, Benzodiazepines, Centers for Disease Control and Prevention, U.S., Communication, Drug Therapy, Combination, Goals, Humans, Drug Prescriptions, Primary Health Care, United States, Randomized Controlled Trials as Topic, Treatment Outcome, Withholding Treatment, Chronic Pain, Acute Pain, Prescription Drug Misuse, Observational Studies as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-09-24 (prompt extract-v1).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
